Compare SCHL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCHL | INMD |
|---|---|---|
| Founded | 1920 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Books | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.4M | 842.0M |
| IPO Year | 1995 | 2018 |
| Metric | SCHL | INMD |
|---|---|---|
| Price | $38.94 | $13.81 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $40.00 | $17.33 |
| AVG Volume (30 Days) | 602.6K | ★ 685.0K |
| Earning Date | 03-19-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | ★ $1,487,100,000.00 | N/A |
| Revenue This Year | $1.88 | $1.74 |
| Revenue Next Year | $4.05 | $3.26 |
| P/E Ratio | $21.45 | ★ $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.78 | $12.72 |
| 52 Week High | $43.39 | $16.74 |
| Indicator | SCHL | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 44.27 |
| Support Level | $37.97 | $13.32 |
| Resistance Level | $39.65 | $13.87 |
| Average True Range (ATR) | 1.41 | 0.30 |
| MACD | -0.23 | -0.08 |
| Stochastic Oscillator | 14.64 | 42.06 |
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.